Loading clinical trials...
Loading clinical trials...
This study is to assess the burden of disease in adolescent and adult participants with moderate or severe alopecia areata (AA), non-segmental vitiligo (NSV), or moderate to severe hidradenitis suppur...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AbbVie
NCT05398809 · Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced), Alopecia Areata
NCT07533019 · Vitiligo, Non-Segmental Vitiligo (NSV)
NCT03967600 · Hidradenitis Suppurativa
NCT06959225 · Hidradenitis Suppurativa
NCT06958211 · Hidradenitis Suppurativa
Hospital Britanico de Buenos Aires /ID# 278940
Ciudad Autonoma de Buenos Aire, Buenos Aires
Buenos Aires Skin /ID# 277637
Buenos Aires
Centro de Investigacion y Prevencion Cardiovascular (CIPREC) /ID# 277634
Buenos Aires
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions